Health Enhancemt Prd (HEPI) 0.1749 $HEPI
Health Enhancement Products, Inc. Reveals Results From Canine Joint Health Study Conducted by Covance Inc.
Marketwire - Mon May 05, 8:06AM CDT
Health Enhancement Products, Inc. (OTCQB: HEPI), a Michigan-based biotech firm investigating bioactive compounds extracted from algal cultures, is pleased to announce preliminary research results for efficacy in supporting canine joint health. The research was conducted at Covance Inc., based in Princeton, New Jersey. Covance is one of the world's largest contract research organizations and a significant contributor to advances in animal therapeutics. Joint health issues are predicted to affect nearly 1 in 5 dogs, and the canine joint health supplement market generates roughly $300 million in annual sales in the US alone.
Health Enhancement Products Announces Commencement of Bovine Mastitis Testing With Contract Research Organization Dairy Experts
Marketwire - Thu Apr 24, 7:25AM CDT
Health Enhancement Products, Inc. (OTCBB: HEPI), a Michigan-based biotech firm investigating bioactive compounds extracted from algal cultures, is pleased to announce the kickoff of a large-scale bovine study to gauge the efficacy of its candidate compounds in addressing mastitis, a condition that affects the health of dairy cows and impacts milk production. Mastitis affects up to 10% of the US dairy herd at any given time and is responsible for nearly $3 billion in lost milk production annually. The US dairy herd numbers 9 million, about 3% of the world's entire population of 244 million dairy cows. Mastitis is a global animal health problem.
Health Enhancement Products, Inc.'s President's Annual Report to Shareholders
Marketwire - Mon Mar 31, 10:21AM CDT
Today, March 31, 2014, the Company filed its 10-K Annual Report with the SEC. The filing can be found at: http://www.sec.gov/cgi-bin/browse-edgar?CIK=0...getcompany
Health Enhancement Products partners with Charles River for canine joint health testing programmes
M2 - Tue Mar 18, 6:14AM CDT
Biotech firm Health Enhancement Products (OTCQB:HEPI) disclosed on Monday the start of a study to gauge the efficacy of its candidate compounds in addressing canine joint health around the world.
Health Enhancement Products Announces Start of Canine Joint Health Testing and Phase Two Synthetic Development Program
Marketwire - Mon Mar 17, 8:40AM CDT
Health Enhancement Products, Inc. (OTCQB: HEPI), a Michigan-based biotech firm investigating bioactive compounds extracted from algal cultures, is pleased to announce the kickoff of a study to gauge the efficacy of its candidate compounds in addressing canine joint health, a condition that affects the quality of life for millions of pet and working dogs around the world. The canine joint health supplement market segment represents $300 million in annual sales in the US alone.
Health Enhancement Products, Inc. Study at the University of Missouri Indicates Positive Results for Canine Joint Health
Marketwire - Mon Feb 03, 1:22PM CST
Health Enhancement Products, Inc. (OTCQB: HEPI), which investigates and licenses algae-derived, high-value bioactive molecules that benefit human and animal health, announces preliminary research results for efficacy in addressing canine joint health. The research was conducted at the University of Missouri by Keiichi Kuroki, DVM, PhD, DAVCP, Associate Director of the Comparative Orthopaedic Laboratory and Associate Professor at the College of Veterinary Medicine.
Health Enhancement Products, Inc. Enters Into Collaborative Agreement With Global Animal Health Company to Accelerate Bovine Mastitis Product
Marketwire - Thu Dec 26, 7:30AM CST
Health Enhancement Products, Inc. (OTCQB: HEPI) has entered into a collaborative/option agreement with a global animal health company, whose name is being withheld for competitive considerations and intellectual property protection for both parties.
Health Enhancement Products, Inc. Expands Corporate Website, Launches Wellness Testing Subsidiary Website
Marketwire - Tue Dec 03, 2:52PM CST
Health Enhancement Products, Inc. (OTCQB: HEPI), which investigates and licenses algae-derived, high-value bioactive molecules that benefit human and animal health, has expanded and upgraded its corporate website and that of its wellness testing subsidiary, WellMetris LLC.
Health Enhancement Products, Inc. Sponsored Research at University of Wisconsin - Madison Yields Positive Results in Bovine Mastitis Testing, Report From Lead Researcher States
Marketwire - Wed Nov 20, 7:02AM CST
Health Enhancement Products, Inc. (OTCBB: HEPI), which investigates and licenses algae-derived, high-value bioactive molecules that benefit human and animal health, has received the results of the first phase of research on the company's bovine mastitis remedy from the University of Wisconsin - Madison, Department of Dairy Science. Laura Hernandez, PhD, has concluded the first phase of the study and validated the bioactivity of HEPI's compounds. She has issued a formal report under the aegis of the University of Wisconsin-Madison.
Health Enhancement Products, Inc. Sponsors Research at Arizona Center for Algae Technology and Innovation and ATP3 to Facilitate Bioactives Commercial Production
Marketwire - Tue Nov 12, 9:34AM CST
Health Enhancement Products, Inc. (OTCBB: HEPI), which investigates and licenses algae-derived, high-value bioactive molecules that benefit human and animal health, has formalized a one-year sponsored research project with the Arizona Center for Algae Technology and Innovation (AzCATI), located at the Arizona State University Polytechnic campus in Mesa, Ariz., and the Algae Test-bed Public-Private Partnership (ATP3).
Health Enhancement Products Inc buys the assets and intellectual property of Wellness Indicators Inc
M2 - Tue Aug 27, 10:17AM CDT
Natural products developer Health Enhancement Products (OTCBB:HEPI) reported on Monday the launch of a series of transactions to acquire the assets and intellectual property of Wellness Indicators Inc.
Health Enhancement Products, Inc. Acquires the Assets and Intellectual Property of Wellness Testing Company in a $1.1 Million Stock and Cash Transaction
Marketwire - Mon Aug 26, 11:45AM CDT
Michigan-based natural products developer Health Enhancement Products (OTCBB: HEPI) executed a series of transactions to acquire the assets and intellectual property of Wellness Indicators, Inc., from the primary lender and collateral agent -- Windsor, Ontario-based Essex Angel Capital (TSX VENTURE: EXC), a Tier 2 investment issuer listed on the Toronto Venture Exchange. Essex had previously exercised its rights on the assets in a Michigan federal court. The transaction was effective Monday, August 19 and presented to shareholders at the annual meeting in Detroit on August 21. The Board of Directors ratified the transaction on the same day in a special session of the board.
Essex Angel Capital Inc. Announces Sale of Assets to Health Enhancement Products, Inc.
Marketwire - Thu Aug 22, 6:48PM CDT
Essex Angel Capital Inc. (TSX VENTURE: EXC) (the "Corporation" or "Essex"
is pleased to announce that, further to its press release dated April 18, 2013, it sold certain assets (the "Assets" of Wellness Indicators, Inc., which it obtained through foreclosure proceedings on the Assets, to Health Enhancements Products Inc. ("HEPI" in exchange for 1,792,315 shares of common stock of HEPI (the "HEPI Shares" at a price per share equal to US$0.31. The HEPI Shares are listed on the OTCBB. The sale of the Assets is subject to receipt of all required regulatory approval, including the approval of the TSX Venture Exchange.
OTC Daily Alert Stock Watch - Health Enhancement Products, Inc. (OTCBB: HEPI)
WorldStockWire - Fri Aug 16, 6:00PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Health Enhancement Products to Hold Annual Shareholder Meeting August 21, 2013 in Detroit, Michigan
Marketwire - Tue Aug 13, 8:14AM CDT
Michigan-based health and wellness company Health Enhancement Products (OTCBB: HEPI) has notified shareholders that the Company's annual shareholder meeting will be held on August 21, 2013 at the Westin Hotel directly adjacent to the McNamara terminal of Detroit Metro Airport (DTW) beginning 10:00AM EDT and concluding at noon.
Health Enhancement Products Inc names John B Payne to board
M2 - Thu Jul 25, 5:02AM CDT
Natural products developer Health Enhancement Products (OTCQB:HEPI) reported on Wednesday the appointment of John B Payne to its board of directors to focus on algae-based bioactives targeting animal health applications.
Health Enhancement Products, Inc. Announces Appointment of John B. Payne as Board Member
Marketwire - Wed Jul 24, 8:14AM CDT
Michigan-based natural products developer Health Enhancement Products (OTCQB: HEPI) announced today that John B. Payne has agreed to join its board of directors. Mr. Payne has a long and distinguished career in the global animal health industry and is currently serving as Chairman of the Board, American Humane Association -- the nation's leading pioneer in the protection of children and animals. John Payne's appointment to the Board complements the Company's focus on algae-based bioactives targeting animal health applications.
Health Enhancement Products, Inc. Receives Notice of Allowance From US Patent Office for Treatment of Disease Using Its Proprietary Algal Phyto-Percolate and Files Two New Patent Applications for Animal Health
Marketwire - Mon Jun 17, 8:30AM CDT
Michigan-based natural products developer Health Enhancement Products (OTCBB: HEPI) was advised by the US Patent Office that a US patent will be issued for Application No. 12/067,735 regarding "Composition and Use of Phyto-Percolate for Treatment of Disease" thereby establishing its claims on novel methods of producing and administering products derived from its proprietary algal cultures. In related news, HEPI directed the Arizona office of the law firm of Snell & Wilmer to file a new provisional patent application that potentially expands the use of its proprietary phyto-percolate and derivative compounds to animal health uses, specifically addressing bovine mastitis, bovine respiratory disease complex, transition cow syndrome, porcine reproductive and respiratory syndrome, and canine osteoarthritis -- primarily auto-immune and metabolic disorders.
Health Enhancement Products, Inc. Reveals Results From Canine Joint Health Study Conducted by Covance Inc.
Marketwire - Mon May 05, 8:06AM CDT
Health Enhancement Products, Inc. (OTCQB: HEPI), a Michigan-based biotech firm investigating bioactive compounds extracted from algal cultures, is pleased to announce preliminary research results for efficacy in supporting canine joint health. The research was conducted at Covance Inc., based in Princeton, New Jersey. Covance is one of the world's largest contract research organizations and a significant contributor to advances in animal therapeutics. Joint health issues are predicted to affect nearly 1 in 5 dogs, and the canine joint health supplement market generates roughly $300 million in annual sales in the US alone.
Health Enhancement Products Announces Commencement of Bovine Mastitis Testing With Contract Research Organization Dairy Experts
Marketwire - Thu Apr 24, 7:25AM CDT
Health Enhancement Products, Inc. (OTCBB: HEPI), a Michigan-based biotech firm investigating bioactive compounds extracted from algal cultures, is pleased to announce the kickoff of a large-scale bovine study to gauge the efficacy of its candidate compounds in addressing mastitis, a condition that affects the health of dairy cows and impacts milk production. Mastitis affects up to 10% of the US dairy herd at any given time and is responsible for nearly $3 billion in lost milk production annually. The US dairy herd numbers 9 million, about 3% of the world's entire population of 244 million dairy cows. Mastitis is a global animal health problem.
Health Enhancement Products, Inc.'s President's Annual Report to Shareholders
Marketwire - Mon Mar 31, 10:21AM CDT
Today, March 31, 2014, the Company filed its 10-K Annual Report with the SEC. The filing can be found at: http://www.sec.gov/cgi-bin/browse-edgar?CIK=0...getcompany
Health Enhancement Products partners with Charles River for canine joint health testing programmes
M2 - Tue Mar 18, 6:14AM CDT
Biotech firm Health Enhancement Products (OTCQB:HEPI) disclosed on Monday the start of a study to gauge the efficacy of its candidate compounds in addressing canine joint health around the world.
Health Enhancement Products Announces Start of Canine Joint Health Testing and Phase Two Synthetic Development Program
Marketwire - Mon Mar 17, 8:40AM CDT
Health Enhancement Products, Inc. (OTCQB: HEPI), a Michigan-based biotech firm investigating bioactive compounds extracted from algal cultures, is pleased to announce the kickoff of a study to gauge the efficacy of its candidate compounds in addressing canine joint health, a condition that affects the quality of life for millions of pet and working dogs around the world. The canine joint health supplement market segment represents $300 million in annual sales in the US alone.
Health Enhancement Products, Inc. Study at the University of Missouri Indicates Positive Results for Canine Joint Health
Marketwire - Mon Feb 03, 1:22PM CST
Health Enhancement Products, Inc. (OTCQB: HEPI), which investigates and licenses algae-derived, high-value bioactive molecules that benefit human and animal health, announces preliminary research results for efficacy in addressing canine joint health. The research was conducted at the University of Missouri by Keiichi Kuroki, DVM, PhD, DAVCP, Associate Director of the Comparative Orthopaedic Laboratory and Associate Professor at the College of Veterinary Medicine.
Health Enhancement Products, Inc. Enters Into Collaborative Agreement With Global Animal Health Company to Accelerate Bovine Mastitis Product
Marketwire - Thu Dec 26, 7:30AM CST
Health Enhancement Products, Inc. (OTCQB: HEPI) has entered into a collaborative/option agreement with a global animal health company, whose name is being withheld for competitive considerations and intellectual property protection for both parties.
Health Enhancement Products, Inc. Expands Corporate Website, Launches Wellness Testing Subsidiary Website
Marketwire - Tue Dec 03, 2:52PM CST
Health Enhancement Products, Inc. (OTCQB: HEPI), which investigates and licenses algae-derived, high-value bioactive molecules that benefit human and animal health, has expanded and upgraded its corporate website and that of its wellness testing subsidiary, WellMetris LLC.
Health Enhancement Products, Inc. Sponsored Research at University of Wisconsin - Madison Yields Positive Results in Bovine Mastitis Testing, Report From Lead Researcher States
Marketwire - Wed Nov 20, 7:02AM CST
Health Enhancement Products, Inc. (OTCBB: HEPI), which investigates and licenses algae-derived, high-value bioactive molecules that benefit human and animal health, has received the results of the first phase of research on the company's bovine mastitis remedy from the University of Wisconsin - Madison, Department of Dairy Science. Laura Hernandez, PhD, has concluded the first phase of the study and validated the bioactivity of HEPI's compounds. She has issued a formal report under the aegis of the University of Wisconsin-Madison.
Health Enhancement Products, Inc. Sponsors Research at Arizona Center for Algae Technology and Innovation and ATP3 to Facilitate Bioactives Commercial Production
Marketwire - Tue Nov 12, 9:34AM CST
Health Enhancement Products, Inc. (OTCBB: HEPI), which investigates and licenses algae-derived, high-value bioactive molecules that benefit human and animal health, has formalized a one-year sponsored research project with the Arizona Center for Algae Technology and Innovation (AzCATI), located at the Arizona State University Polytechnic campus in Mesa, Ariz., and the Algae Test-bed Public-Private Partnership (ATP3).
Health Enhancement Products Inc buys the assets and intellectual property of Wellness Indicators Inc
M2 - Tue Aug 27, 10:17AM CDT
Natural products developer Health Enhancement Products (OTCBB:HEPI) reported on Monday the launch of a series of transactions to acquire the assets and intellectual property of Wellness Indicators Inc.
Health Enhancement Products, Inc. Acquires the Assets and Intellectual Property of Wellness Testing Company in a $1.1 Million Stock and Cash Transaction
Marketwire - Mon Aug 26, 11:45AM CDT
Michigan-based natural products developer Health Enhancement Products (OTCBB: HEPI) executed a series of transactions to acquire the assets and intellectual property of Wellness Indicators, Inc., from the primary lender and collateral agent -- Windsor, Ontario-based Essex Angel Capital (TSX VENTURE: EXC), a Tier 2 investment issuer listed on the Toronto Venture Exchange. Essex had previously exercised its rights on the assets in a Michigan federal court. The transaction was effective Monday, August 19 and presented to shareholders at the annual meeting in Detroit on August 21. The Board of Directors ratified the transaction on the same day in a special session of the board.
Essex Angel Capital Inc. Announces Sale of Assets to Health Enhancement Products, Inc.
Marketwire - Thu Aug 22, 6:48PM CDT
Essex Angel Capital Inc. (TSX VENTURE: EXC) (the "Corporation" or "Essex"
is pleased to announce that, further to its press release dated April 18, 2013, it sold certain assets (the "Assets" of Wellness Indicators, Inc., which it obtained through foreclosure proceedings on the Assets, to Health Enhancements Products Inc. ("HEPI" in exchange for 1,792,315 shares of common stock of HEPI (the "HEPI Shares" at a price per share equal to US$0.31. The HEPI Shares are listed on the OTCBB. The sale of the Assets is subject to receipt of all required regulatory approval, including the approval of the TSX Venture Exchange. OTC Daily Alert Stock Watch - Health Enhancement Products, Inc. (OTCBB: HEPI)
WorldStockWire - Fri Aug 16, 6:00PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Health Enhancement Products to Hold Annual Shareholder Meeting August 21, 2013 in Detroit, Michigan
Marketwire - Tue Aug 13, 8:14AM CDT
Michigan-based health and wellness company Health Enhancement Products (OTCBB: HEPI) has notified shareholders that the Company's annual shareholder meeting will be held on August 21, 2013 at the Westin Hotel directly adjacent to the McNamara terminal of Detroit Metro Airport (DTW) beginning 10:00AM EDT and concluding at noon.
Health Enhancement Products Inc names John B Payne to board
M2 - Thu Jul 25, 5:02AM CDT
Natural products developer Health Enhancement Products (OTCQB:HEPI) reported on Wednesday the appointment of John B Payne to its board of directors to focus on algae-based bioactives targeting animal health applications.
Health Enhancement Products, Inc. Announces Appointment of John B. Payne as Board Member
Marketwire - Wed Jul 24, 8:14AM CDT
Michigan-based natural products developer Health Enhancement Products (OTCQB: HEPI) announced today that John B. Payne has agreed to join its board of directors. Mr. Payne has a long and distinguished career in the global animal health industry and is currently serving as Chairman of the Board, American Humane Association -- the nation's leading pioneer in the protection of children and animals. John Payne's appointment to the Board complements the Company's focus on algae-based bioactives targeting animal health applications.
Health Enhancement Products, Inc. Receives Notice of Allowance From US Patent Office for Treatment of Disease Using Its Proprietary Algal Phyto-Percolate and Files Two New Patent Applications for Animal Health
Marketwire - Mon Jun 17, 8:30AM CDT
Michigan-based natural products developer Health Enhancement Products (OTCBB: HEPI) was advised by the US Patent Office that a US patent will be issued for Application No. 12/067,735 regarding "Composition and Use of Phyto-Percolate for Treatment of Disease" thereby establishing its claims on novel methods of producing and administering products derived from its proprietary algal cultures. In related news, HEPI directed the Arizona office of the law firm of Snell & Wilmer to file a new provisional patent application that potentially expands the use of its proprietary phyto-percolate and derivative compounds to animal health uses, specifically addressing bovine mastitis, bovine respiratory disease complex, transition cow syndrome, porcine reproductive and respiratory syndrome, and canine osteoarthritis -- primarily auto-immune and metabolic disorders.
